| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.6M | -6.1% |
| R&D Expense | $250K | -18.6% |
| SG&A Expense | $28.3M | +22.7% |
| Operating Income | -$6.3M | -344.6% |
| Interest Expense | $2.1M | -48.9% |
| Pre-tax Income | -$9.6M | — |
| Income Tax | $106K | -71.0% |
| Net Income | -$9.7M | -2134.2% |
| EPS (Basic) | -$0.34 | -1600.0% |
| EPS (Diluted) | -$0.34 | -1600.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.8M | +38.1% |
| Accounts Receivable | $23.2M | +80.2% |
| Current Assets | $67.0M | +51.9% |
| Total Assets | $70.6M | +57.0% |
| Current Liabilities | $10.5M | +52.0% |
| Total Liabilities | $35.1M | -31.0% |
| Stockholders' Equity | $35.5M | +704.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | -146.2% |
| Financing Cash Flow | $22.6M | +266.2% |